TriVascular Technologies

TriVascular’s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, TriVascular’s products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR.

Type
Subsidiary
Parent Company
Endologix
HQ
Irvine, US
Founded
1998
TriVascular Technologies was founded in 1998 and is headquartered in Irvine, US

TriVascular Technologies Office Locations

TriVascular Technologies has offices in Irvine, Santa Rosa and Rosmalen
Santa Rosa, US (HQ)
3910 Brickway Blvd
Irvine, US (HQ)
2 Musick
Rosmalen, NL
40 Burgemeester Burgerslaan

TriVascular Technologies Data and Metrics

TriVascular Technologies Summary

Founding Date

1998
TriVascular Technologies is a subsidiary of Endologix

Traffic Overview of TriVascular Technologies

TriVascular Technologies News and Updates

The Diagnosis: Investors, Corporate Execs, and Regulators Sound Off On Medical Device Innovation

Funding to the medical device sector has held steady at $3.3B or more in the last four years and is spread out among multiple specialties, including cardiology, surgery, diagnostics, and opthamology. Key players and investors alike in the industry believe … Continued

TriVascular Technologies Company Life and Culture

You may also be interested in